Abcellera Biologics Inc. is trading at $5.93, a gain of 3.67% today, as investors look ahead to the company's presentation at a major investor conference.
- The positive move comes ahead of the company's scheduled presentation at the Jefferies Global Healthcare Conference today, June 4.
- This follows a sharp two-day decline where the share price dropped from $6.46 on June 1 to $5.72 at the prior close, amid elevated volatility.
- The stock has been active recently, hitting a 52-week high on June 1 after reporting positive clinical trial data in May.